Loading...
Minnesota Criminal Justice Statute Service
Search
Subscribe to Updates
Reports
Statute Change Report
About
Glossary
Quick Search
152.02.3(b)(1)
Statute ID:
18598
Statute Function ID:
37957
Drugs - Schedule II Controlled Substances - Opium and opiate, and any salt, compound, derivative
In Effect
New Search
Refine Search
Back to Results
Function Details
History
Text
Details are only available for Penalty and Charging Statutes.
Statute Number:
152.02.3(b)(1)
Enactment Date:
May 19, 2023
Effective Date:
May 20, 2023
Expiration Date:
Repealed?:
No
Summary Text:
Drugs - Schedule II Controlled Substances - Opium and opiate, and any salt, compound, derivative
Statute ID:
18598
Created:
May 20, 2023 by mnjis.legal.analyst@state.mn.us
Updated:
May 20, 2023 by mnjis.legal.analyst@state.mn.us
Last Update Action:
Added
Legal Analyst Comment:
Amended 2023 C52 Art16 Sect2; Effective 05/20/2023
Summary Text:
Drugs - Schedule II Controlled Substances - Opium and opiate, and any salt, compound, derivative
Link to MN Statute Text:
https://www.revisor.leg.state.mn.us/stats/152/02.html
Legislative Session:
2023 - Regular
Session Law Text?:
No
Statute text last updated on:
May 20, 2023
(a) Schedule II: consists of the substances listed in this subdivision. (b) Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis: (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate. (i) Excluding: (A) apomorphine; (B) thebaine-derived butorphanol; (C) dextrophan; (D) nalbuphine; (E) nalmefene; (F) naloxegol; (G) naloxone; (H) naltrexone; and (I) and their respective salts; (ii) but including the following: (A) opium, in all forms and extracts; (B) codeine; (C) dihydroetorphine; (D) ethylmorphine; (E) etorphine hydrochloride; (F) hydrocodone; (G) hydromorphone; (H) metopon; (I) morphine; (J) oxycodone; (K) oxymorphone; (L) thebaine; (M) oripavine; (2) any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in clause (a) (1), except that these substances shall not include the isoquinoline alkaloids of opium.; (3) opium poppy and poppy straw; (4) coca leaves and any salt, cocaine compound, derivative, or preparation of coca leaves, (including cocaine and ecgonine and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; (c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, or unless listed in another schedule, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: (1) alfentanil; (2) alphaprodine; (3) anileridine; (4) bezitramide; (5) bulk dextropropoxyphene (nondosage forms); (6) carfentanil; (7) dihydrocodeine; (8) dihydromorphinone; (9) diphenoxylate; (10) fentanyl; (11) isomethadone; (12) levo-alpha-acetylmethadol (LAAM) (13) levomethorphan; (14) levorphanol; (15) metazocine; (16) methadone; (17) methadone - intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane; (18) moramide - intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid; (19) pethidine; (20) pethidine - intermediate - a, 4-cyano-1-methyl-4-phenylpiperidine; (21) pethidine - intermediate - b, ethyl-4-phenylpiperidine-4-carboxylate; (22) pethidine - intermediate - c, 1-methyl-4-phenylpiperidine-4-carboxylic acid; (23) phenazocine; (24) piminodine; (25) racemethorphan; (26) racemorphan; (27) remifentanil; (28) sufentanil; (29) tapentadol; (30) 4-Anilino-N-phenethyl-4-piperidine (ANPP); (31) oliceridine; (32) norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide). (d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system: (1) amphetamine, its salts, optical isomers, and salts of its optical isomers; (2) methamphetamine, its salts, isomers, and salts of its isomers; (3) phenmetrazine and its salts; (4) methylphenidate; (5) lisdexamfetamine. (e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) amobarbital; (2) glutethimide; (3) secobarbital; (4) pentobarbital; (5) phencyclidine; (6) phencyclidine immediate precursors: (i) 1-phenylcyclohexylamine; (ii) 1-piperidinocyclohexanecarbonitrile; (7) phenylacetone. (f) Hallucinogenic substances: nabilone.
